![]() |
市场调查报告书
商品编码
1374407
超音波换能器全球市场规模、份额、产业趋势分析报告:2023-2030 年按产品类型、最终应用、地区分類的展望与预测Global Ultrasound Transducer Market Size, Share & Industry Trends Analysis Report By Product Type, By End Use (Hospital, Clinic, Diagnostic Center, and ASCs), By Application, By Regional Outlook and Forecast, 2023 - 2030 |
预计到 2030 年,全球超音波换能器市场规模将达到 49 亿美元,预测期内年复合成长率3.6%。 2022年市场规模为193.39万辆,成长率为4.0%(2019-2022年)。
根据 KBV 基数矩阵中提出的分析,三星电子有限公司(三星集团)(三星麦迪逊有限公司)于 2020 年 10 月宣布,新型超音波系统 HERA W10 和椅式超音波系统 HERA I10 推出原型并交付改进的技术和产品,影像品质达到新的水平。 GE医疗保健技术有限公司、深圳迈瑞生物医疗电子有限公司和日立公司(日立医疗保健)等公司是该市场的主要创新者。
COVID-19 影响分析
超音波换能器在大流行期间发挥了重要作用,特别是在评估 COVID-19 患者方面。床边超音波(床边超音波,POCUS)广泛用于监测加加护病房(ICU)和急诊的 COVID-19 患者的肺功能状态、心臟功能和血管通路。这场大流行加速了护理点超音波(POCUS) 作为快速诊断和病患管理的宝贵工具的采用。医疗保健提供者已转向使用包含高功率、一次性换能器的手持式超音波诊断设备,以最大程度地减少辐射暴露并改善患者照护。医疗保健系统和设施重视拥有现成的、便携式的和多功能的影像成像工具,例如超音波换能器,以应对未来的卫生紧急情况。Masu。总之,COVID-19 大流行对市场造成了短期破坏和长期变革影响。
市场成长要素
尖端医疗设备投资
医疗保健支出的增加是超音波换能器需求不断增长的主要驱动力。医疗保健支出包括政府、医疗保健提供者、保险公司和个人为提供和获得医疗保健服务而进行的投资。不断增长的医疗保健支出使医疗机构和设施能够分配预算来采购先进的医疗设备,包括超音波设备和换能器。这些投资旨在实现医疗基础设施现代化并提高所提供的护理品质。不断增加的医疗保健支出直接用于妇幼保健服务,而超音波是生产护理、监测胎儿发育和评估孕产妇健康状况的基本工具。对妇女和儿童健康的关注推动了需求。
提高对超音波影像的认识
人们对超音波影像优势的认识不断提高,增加了超音波临床应用的频率和种类,在患者照护和医学决策方面发挥关键作用。非侵入性和安全性是超音波换能器成为医疗保健领域首选诊断工具的两个重要特性。这些属性促进了超音波影像的广泛采用和患者接受。超音波影像成像完全是非侵入性的,不需要插入仪器或使用电离辐射。这种非侵入性特性消除了手术切口的需要,并减少了相关的风险和併发症。超音波检查不需要使用显影剂,造影剂可能会引起某些人的过敏反应。这提高了安全性,特别是对于已知对显影剂过敏的患者。所有这些都可能成为未来年度市场扩张的主要动力。
市场抑制因素
与先进感测器相关的高初期成本
与已开发国家相比,新兴国家的财政资源往往较为有限,人均所得也较低。先进超音波设备的高昂初期成本使医疗保健预算紧张,并使医疗保健组织难以投资此类技术。发展中地区的医疗基础设施往往不发达或装备落后。将大部分预算分配给昂贵的影像影像设备可能被视为与其他紧迫的医疗保健优先事项的权衡。发展中地区可能担心昂贵设备的长期永续性,例如备件和技术支援的可用性,并且可能不愿意投资初期成本。这些因素很可能使超音波换能器市场未来的扩张变得困难。
产品类型展望
依产品类型分为线性、凸面、相控阵、端腔、CW多普勒等。 2022 年,相控阵细分市场在市场中占据了重要的收益占有率。相控阵换能器对于心臟成像,尤其心臟超音波图至关重要。电子控制超音波束的能力可以实现心臟结构的精确可视化和心臟功能的即时评估。随着心血管疾病(CVD)的增加,心臟超音波的需求显着增加。血管超音波使用相控阵换能器来可视化动脉和静脉等血管。
最终用途展望
根据最终用途,市场分为医院、诊所、诊断中心和门诊手术中心(ASC)。 2022年,诊所业务在市场中获得了可观的收益占有率。诊所强调预防医学和健康检查。超音波换能器可以筛检乳癌、甲状腺疾病、腹部疾病等,并实现早期发现和干预,在预防保健中发挥重要作用。门诊病人医师越来越多地采用护理点超音波(POCUS) 来加强患者照护。
应用前景
依应用划分,市场分为心血管、普通影像、肌肉骨骼、妇产科、血管等。 2022 年,妇产科领域在市场中获得了可观的收益占有率。妇产科超音波换能器使医疗保健提供者能够监测整个怀孕期间的胎儿发育,从而有助于生产护理。评估胎儿生长、检测异常、确定婴儿位置并评估胎盘。准妈妈的父母可以透过超音波看到胎儿并与胎儿建立连结。随着母亲生产时年龄的增加,某些併发症的风险也会增加。高风险妊娠通常需要更频繁和更先进的产前监测,包括超音波。
区域展望
从区域来看,市场分为北美、欧洲、亚太地区、拉丁美洲、中东和非洲。 2022 年,北美市场收益占有率最高。北美拥有先进的医疗保健基础设施,包括最先进的医疗设施、医院、诊所和诊断中心。该基础设施对超音波换能器等先进医疗技术产生了强烈需求,以支援高品质的患者照护。该地区心血管病、糖尿病、肥胖等慢性病盛行率较高。超音波换能器对于这些慢性疾病的诊断、监测和管理至关重要,并有助于满足不断增长的需求。所有这些因素都可能支持未来北美市场的扩张。
The Global Ultrasound Transducer Market size is expected to reach $4.9 billion by 2030, rising at a market growth of 3.6% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,933.9 thousand units, experiencing a growth of 4.0% (2019-2022).
The demand for routine diagnostic imaging remains steady due to its essential role in healthcare. Consequently, the General Imaging segment registered a $1,329.6 million revenue in the market in 2022. General imaging transducers are ideal for routine diagnostic examinations. They are commonly used for general health assessments, such as evaluating abdominal organs, assessing the female reproductive system, and monitoring the progression of pregnancies. They are used to detect conditions like breast cancer, prostate cancer, and thyroid disorders early. The increasing emphasis on preventative healthcare drives the demand for these transducers. Therefore, the general imaging segment has the potential for high growth in the future.
The major strategies followed by the market participants are Product Launches as the key developmental strategy to keep pace with the changing demands of end users. For instance In July, 2022, GE HealthCare Technologies, Inc. released Voluson Expert 22, the most advanced ultrasound yet. The launched product would produce the best quality images and would provide greater flexibility in imaging functions. Additionally, In September, 2022, FUJIFILM Sonosite Inc. launched Sonosite LX system in several European countries, to support clinicians in using transoesophageal ultrasound at the point of care, both of which are created to be used with the Sonosite LX and Sonosite PX.
Based on the Analysis presented in the KBV Cardinal matrix; Samsung Electronics Co., Ltd. (Samsung Group) (Samsung Medison Co., Ltd.) is the major forerunner in the Market. In October, 2020, Samsung Medison launched a new ultrasound system HERA W10 and prototype of a chair-type ultrasound system HERA I10, to deliver improved technology and offerings with a new level of image quality. Companies such as GE HealthCare Technologies, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and Hitachi, Ltd. (Hitachi Healthcare) are some of the key innovators in Market.
COVID-19 Impact Analysis
Ultrasound transducers were crucial in critical care settings during the pandemic, especially in assessing COVID-19 patients. Bedside ultrasound (point-of-care ultrasound or POCUS) was widely used to monitor lung conditions, cardiac function, and vascular access in COVID-19 patients in intensive care units (ICUs) and emergency departments. The pandemic accelerated the adoption of point-of-care ultrasound (POCUS) as a valuable tool for rapid diagnostics and patient management. Healthcare providers turned to handheld ultrasound devices, including high-powered, single-use transducers, to minimize exposure and enhance patient care. Healthcare systems and facilities emphasize having readily available, portable, and versatile imaging tools like ultrasound transducers to respond to future health emergencies. In conclusion, the COVID-19 pandemic had short-term disruptions and long-term transformative effects on the market.
Market Growth Factors
Advanced medical equipment investment
Increased healthcare spending is a significant driver behind the growing demand for ultrasound transducers. Healthcare spending encompasses investments made by governments, healthcare institutions, insurers, and individuals to provide and access healthcare services. Higher healthcare spending allows healthcare institutions and facilities to allocate budgets for procuring advanced medical equipment, including ultrasound machines and transducers. These investments aim to modernize healthcare infrastructure and improve the quality of care provided. Increased healthcare spending is directed toward maternal and child healthcare services, where ultrasound is a fundamental tool for prenatal care, monitoring fetal development, and assessing maternal health. This focus on women's and children's health will drive demand.
Growing awareness of ultrasound imaging
The growing awareness of the benefits of ultrasound imaging has led to more frequent and diverse clinical applications of ultrasound and has also played a pivotal role in shaping patient care and medical decision-making. Non-invasiveness and safety are two key attributes that make ultrasound transducers a preferred diagnostic tool in healthcare. These qualities contribute to the widespread adoption and patient acceptance of ultrasound imaging. Ultrasound imaging is entirely non-invasive, meaning it does not require the insertion of instruments or the use of ionizing radiation. This non-invasive nature eliminates the need for surgical incisions, reducing the associated risks and complications. Ultrasound does not require using contrast agents that can trigger allergic reactions in some individuals. This enhances safety, especially for patients with known allergies to contrast materials. All these will significantly drive the expansion of market in the coming years.
Market Restraining Factors
High upfront costs associated with advanced transducers
Developing regions often have limited financial resources and lower per capita income than developed countries. High upfront costs for advanced ultrasound equipment can strain healthcare budgets and make it difficult for healthcare institutions to invest in such technology. Healthcare infrastructure in developing regions may be underdeveloped or inadequately equipped. Allocating a significant part of the budget to expensive imaging equipment may be seen as a trade-off against other pressing healthcare priorities. Developing regions may have concerns about the long-term sustainability of expensive equipment, including the availability of spare parts and technical support, which can create reluctance to invest in advanced technology with high upfront costs. These elements will make it difficult for the ultrasonic transducer market to expand in the coming years.
Product Type Outlook
Based on product type, the market is divided into linear, convex, phased array, endocavitary, CW doppler, and others. The phased array segment procured a noticeable revenue share in the market in 2022. Phased array transducers are essential in cardiac imaging, particularly for echocardiography. Their ability to electronically steer the ultrasound beam allows for precise visualization of cardiac structures and real-time assessment of heart function. With the growing incidences of cardiovascular diseases (CVD), the demand for cardiac ultrasound has grown significantly. Vascular ultrasound relies on phased array transducers to visualize blood vessels, including arteries and veins.
End Use Outlook
By end use, the market is segmented into hospital, clinics, diagnostic center, and ambulatory surgery centers (ASCs). In 2022, the clinic segment acquired a substantial revenue share in the market. Clinics emphasize preventive medicine and health screenings. Ultrasound transducers play a vital role in preventative care by enabling screenings for conditions like breast cancer, thyroid disorders, and abdominal issues, allowing for early detection and intervention. Clinicians in outpatient settings increasingly adopt point-of-care ultrasound (POCUS) to enhance patient care.
Application Outlook
On the basis of application, the market is segmented into cardiovascular, general imaging, musculoskeletal, OB/GYN, vascular, and others. The OB/GYN segment acquired a significant revenue share in the market in 2022. OB/GYN ultrasound transducers are instrumental in prenatal care, allowing healthcare providers to monitor fetal development throughout pregnancy. They assess fetal growth, detect anomalies, determine the baby's position, and evaluate the placenta. Expectant parents rely on ultrasound scans for visualizing and bonding with their unborn child. As maternal age at childbirth increases, the risk of certain complications also rises. High-risk pregnancies often require more frequent and advanced prenatal monitoring, including ultrasound examinations.
Regional Outlook
Based on region, the market is divided into North America, Europe, Asia Pacific, and LAMEA. The North America segment recorded the highest revenue share in the market in 2022. North America boasts advanced healthcare infrastructure, including state-of-the-art medical facilities, hospitals, clinics, and diagnostic centers. This infrastructure creates a robust demand for advanced medical technologies like ultrasound transducers to support high-quality patient care. The region has a relatively high prevalence of chronic diseases, such as cardiovascular conditions, diabetes mellitus, and obesity. Ultrasound transducers are essential for diagnosing, monitoring, and managing these chronic illnesses, contributing to their growing demand. All these factors will assist in expanding the North America segment in the future.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GE HealthCare Technologies, Inc., Siemens Healthineers AG (Siemens AG), FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation), Canon, Inc. (Canon Medical Systems Corporation), Hitachi, Ltd. (Hitachi Healthcare), SonoScape Medical Corp., Koninklijke Philips N.V., Samsung Electronics Co., Ltd. (Samsung Group) (Samsung Medison Co., Ltd.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. and Esaote SpA
Recent Strategies Deployed in Ultrasound Transducer Market
Product Launches and Product Expansions
Jan-2023: FUJIFILM Sonosite, Inc. revealed the Sonosite PX ultrasound system. The newest version of Sonosite POCUS, called Sonosite PX, offers the highest level of visual quality ever seen in a Sonosite system, as well as a number of features that help with workflow efficiency and a flexible form factor. The device offers a novel and adjustable work surface that can be employed in a horizontal or vertical position depending on the situational needs of the exam in order to increase clinician ergonomics and productivity.
Nov-2022: Philips released the compact 5000 series, a new compact ultrasound system. The Compact 5000 series make it easier for more patients to have their ultrasound exams done correctly the first time around because of its portability and versatility without sacrificing image quality or performance.
Sep-2022: FUJIFILM Sonosite Inc. launched Sonosite LX system in several European countries. Following this launch, the company also released T8-3 transoesophageal transducer and Cardiac Resuscitation exam type to support clinicians in using transoesophageal ultrasound at the point of care, both of which are created to be used with the Sonosite LX and Sonosite PX.
Jul-2022: GE HealthCare Technologies, Inc. released Voluson Expert 22, the most advanced ultrasound yet. The launched product would produce the best quality images and would provide greater flexibility in imaging functions.
Jun-2022: Mindray unveiled TEX20 Series, best-in-class Point of Care ultrasound system. With its patient-centred information solution, extraordinary image clarity, clinically oriented workflow, smart tools, and intelligent design, this ground-breaking point of care system, the TEX20 Series, dramatically alters the conventional perspective of POC ultrasonography from its predecessors. It offers all the details needed to make decisions for follow-up and quality control.
May-2021: Esaote launched the new MyLab X9 ultrasound system. This system provides the top level of image quality and data processing capability, utilizing the new technological solutions to explore the latest frontiers of ultrasound imaging.
Mar-2021: GE Healthcare today unveiled Venue Fit, a streamlined and compact POCUS system, alongside an industry-first AI offering for cardiac imaging. The Venue Fit is the smallest system in the Venue Family from GE Healthcare, with a tiny footprint designed to fit in confined places, an easy-to-clean touchscreen, and straightforward scanning tools. The new Venue Fit ultrasound device enables healthcare professionals who work in constrained areas to get immediate imaging insights.
Mar-2021: GE Healthcare released Vscan Air, hand-held ultrasound device. The new product is completely wireless, links to a smartphone app, and enables patients to safely access the images. Trained healthcare professionals can use the gadget to immediately test blood flow, and gallbladder illness, and analyze and monitor Covid-19 through a lung exam.
Mergers & Acquisition
Jul-2023: Shenzhen Mindray Bio-Medical Electronics Co., Ltd. announced an agreement to acquire a 75% equity interest in DiaSys Diagnostic Systems GmbH. Through this acquisition, Mindray would significantly strengthen its international supply chain infrastructure and assist the expansion of our IVD business into medium- to large-sized customer sectors. Both companies will work together to realize synergies and increase value for our customers.
Sep-2021: GE Healthcare completed the acquisition of BK Medical, a company that offers ultrasound technology. The acquisition would help GE Healthcare expand its ultrasound offerings into surgical visualization and fuel the growth in precision health.
Partnerships, Collaborations & Agreements
Sep-2021: GE Healthcare joined hands with UltraSight, a digital health pioneer transforming cardiac imaging through the power of AI. The images of an astronaut's heart in microgravity would be captured using the real-time AI guidance software of UltraSight and the portable GE Vscan AirTM, a high-performance, wireless pocket-sized color ultrasound from GE Healthcare.
Jan-2021: Hitachi entered into an agreement with Olympus Corporation, a manufacturer of optics and reprography products. With this agreement, the company aimed to offer better diagnostic and treatment to patients and healthcare professionals.
Market Segments covered in the Report:
By Product Type (Volume, Thousand Units, USD Million, 2019-2030)
By End Use (Volume, Thousand Units, USD Million, 2019-2030)
By Application (Volume, Thousand Units, USD Million, 2019-2030)
By Geography (Volume, Thousand Units, USD Million, 2019-2030)
Companies Profiled
Unique Offerings from KBV Research